Patient-derived organoids predict responses to chemotherapy and PARP inhibitors in advanced ovarian cancer
2026 · Journal of Translational Medicine · 0 citations
https://doi.org/10.1186/s12967-025-07112-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
6
Citations
1
h-index
0
i10-index
Haixia Wang is an academic researcher from Chongqing Cancer Hospital. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & PARP inhibition in cancer therapy & Viral-associated cancers and disorders. The author has an h-index of 1, co-authored 3 publications.
ORCID: 0000-0002-4847-1421Click to start Chat